Paxil Poses High Breast Cancer Risk

 

As many women take antidepressants like Paxil, they literally put themselves at risk for breast cancer. It seems that instead of helping curb depression and its effects, this antidepressant actually increases estrogen in the body. This makes the risk for cancer higher.

Paxil Poses High Breast Cancer Risk“The popular antidepressant Paxil has been linked to the development of breast cancer in women, according to a study that uses new testing methods to easily detect chemicals that can upset human hormonal balance.

According to the Los Angeles Times, California researchers used this new technique to screen nearly 450 different drugs that are commonly used, but it was Paxil (also known as the chemical paroxetine) that quickly caught their attention.

Since Paxil can have a “weak estrogenic effect” on women’s bodies, it could actually act as an estrogen promoter and raise cancer risks. Considering that the presence of estrogen can contribute to the development of 70 percent of all breast cancers, the new findings are particularly relevant.

Complicating the situation is that nearly 25 percent of women aged 40-60 are taking antidepressants in the United States that fall into the same category as Paxil. Almost one-percent of breast cancer patients also suffer from depression, meaning their situation could be made worse by taking such drugs.

These new results follow a Canadian study from 2010 that found breast cancer patients taking Paxil alongside tamoxifen in order to keep the disease at bay were more ultimately likely to die of breast cancer.

“The paroxetine finding helps explain previous studies showing that it reduces tamoxifen therapy’s effectiveness,” lead author and Ph.D. Shiuan Chen, chair of the City of Hope’s Department of Cancer Biology, said in a press release “And it has implications for patients with estrogen-sensitive breast cancer who are on other medications.”

 Read More.

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris was born in Europe but has lived in the US for many years. He attended college both in Europe and the US and completed medical school at the University of Texas. Residency and fellowship in oncology was completed at Baylor. Read More...
Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton